Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-term, Randomized, Double-blind, Multicenter, Parallel-group, Phase III Study Evaluating the Efficacy and Safety of PT027 Compared to PT007 Administered as Needed in Response to Symptoms in Symptomatic Adults and Children 4 Years of Age or Older With Asthma

NCT03769090 is registered in ClinicalTrials.gov with Bond Avillion 2 Development LP as lead sponsor.

NCT NCT03769090
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03769090 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-term, Randomized, Double-blind, Multicenter, Parallel-group, Phase III Study Evaluating the Efficacy and Safety of PT027 Compared to PT007 Administered as Needed in Response to Symptoms in Symptomatic Adults and Children 4 Years of Age or Older With Asthma
Lead sponsor
Bond Avillion 2 Development LP
Phase
Phase 3
Overall status
Completed
Start date
December 13, 2018
Completion date
February 7, 2022
Enrollment
3,132 (actual)
Sites
345

Conditions

As the registry lists them; a condition with its own page is linked.

asthma